The History of Classification and Thresholds in von Willebrand Disease

Prev
 1 / 20 
Next
Prev
 1 / 20 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • explain why VWD classification converts a continuous biological trait into clinical categories
  • distinguish quantitative deficiency, qualitative dysfunction, and virtually complete VWF deficiency
  • interpret the clinical significance of the 30 to 50 IU/dL VWF range
  • compare older low-VWF frameworks with the 2021 ASH/ISTH/NHF/WFH diagnostic approach
  • recognize how diagnostic labels can improve care while also creating risk of overdiagnosis
  • apply bleeding history, repeat testing, family history, and laboratory patterns to borderline cases
  • identify why classification supports judgment rather than replacing it

Which statement best captures the central problem of VWD classification?

a
VWF levels naturally divide into normal and abnormal populations
A is incorrect because VWF levels do not form two natural populations.
b
VWD categories are unnecessary because all patients bleed the same way
B is incorrect because VWD phenotypes vary widely, and categories help guide care.
c
clinicians must draw practical diagnostic lines across a continuous biological spectrum
C is correct because VWF levels are continuously distributed and influenced by many modifiers. Classification is necessary for clinical action, but the lines are imposed on a spectrum.
d
classification is determined by VWF gene sequencing alone
D is incorrect because genetics informs classification but does not define all cases, especially mild type 1 or borderline low VWF.

A patient has proportionally reduced VWF antigen and platelet-dependent VWF activity, with normal multimers. Which category does this pattern most strongly suggest?

a
Type 1 VWD
A is correct because type 1 VWD is a partial quantitative deficiency in which antigen and activity are often reduced in parallel.
b
Type 2A VWD
B is incorrect because type 2A typically involves loss of high-molecular-weight multimers and disproportionate functional impairment.
c
Type 2B VWD
C is incorrect because type 2B involves increased VWF-platelet binding and may cause loss of large multimers or thrombocytopenia.
d
Type 2N VWD
D is incorrect because type 2N is primarily a defect in FVIII binding.

What is the best conceptual distinction between type 1 and type 2 VWD?

a
Type 1 is qualitative, while type 2 is quantitative
A is incorrect because the relationship is reversed.
b
Type 1 reflects reduced VWF amount, while type 2 reflects abnormal VWF function
B is correct because type 1 is partial quantitative deficiency and type 2 is qualitative dysfunction.
c
Type 1 always has severe bleeding, while type 2 is always m
C is incorrect because bleeding severity varies in both categories.
d
Type 1 is acquired, while type 2 is inherited
D is incorrect because both type 1 and type 2 are inherited forms, although acquired VWF disorders also exist.

Why did type 2 VWD require subdivision into 2A, 2B, 2M, and 2N?

a
because all type 2 patients had identical laboratory profiles
A is incorrect because type 2 VWD is heterogeneous.
b
because different qualitative VWF defects had different mechanisms and clinical implications
B is correct because type 2 subtypes reflect different mechanisms: multimer loss, excessive platelet binding, impaired platelet-dependent function despite relatively preserved multimers, and impaired FVIII binding.
c
because type 2 VWD was found to be a laboratory artifact
C is incorrect because type 2 VWD reflects real qualitative VWF dysfunction.
d
because VWF antigen testing alone could distinguish all subtypes
D is incorrect because antigen alone cannot define type 2 subtypes.

A patient has low FVIII with a VWF defect that impairs FVIII binding. What diagnostic pitfall does this create?

a
It can mimic mild hemophilia A
A is correct because type 2N VWD can present with low FVIII and resemble mild hemophilia A unless VWF binding or genetic testing clarifies the mechanism.
b
It proves type 3 VWD
B is incorrect because type 3 VWD involves virtually complete VWF deficiency.
c
It excludes VWD
C is incorrect because impaired FVIII binding is a recognized VWD mechanism.
d
It confirms platelet-type VWD
D is incorrect because platelet-type VWD involves platelet GPIb gain-of-function, not FVIII binding.

Which statement best describes the 30 to 50 IU/dL VWF range?

a
It always represents clinically important inherited VWD
A is incorrect because many individuals in this range do not have clinically significant bleeding or identifiable VWF variants.
b
It is always normal and should be ignored
B is incorrect because some patients in this range have important bleeding phenotypes.
c
It is a boundary zone where bleeding phenotype, repeat testing, family history, and clinical context matter
C is correct because the 30 to 50 IU/dL range can reflect disease-associated bleeding, a risk factor, physiologic variation, or coincidental overlap with common bleeding symptoms.
d
It confirms type 2 VWD
D is incorrect because type 2 VWD requires evidence of qualitative dysfunction.

How did older frameworks often distinguish type 1 VWD from low VWF?

a
Type 1 VWD was usually reserved for VWF below 30 IU/dL, while low VWF referred to 30 to 50 IU/dL with bleeding
A is correct because older frameworks often used a lower threshold for type 1 VWD and a separate “low VWF” label for bleeding patients with levels in the 30 to 50 IU/dL range.
b
Type 1 VWD was defined by normal VWF levels, while low VWF was defined by thrombocytopenia
B is incorrect because type 1 VWD is not defined by normal VWF levels.
c
Type 1 VWD required abnormal multimers, while low VWF required normal FVIII
C is incorrect because type 1 and low VWF are quantitative concepts, not primarily multimer-based categories.
d
Type 1 VWD was acquired, while low VWF was inherited
D is incorrect because the inherited versus acquired distinction does not define this threshold debate.

What was the practical effect of the 2021 ASH/ISTH/NHF/WFH diagnostic guideline for patients with abnormal bleeding and VWF levels below 50 IU/dL?

a
It removed VWF levels from diagnostic consideration
A is incorrect because VWF levels remain central.
b
It required VWF gene sequencing in all patients
B is incorrect because because VWF levels remain central.
c
It classified all such patients as type 2B VWD
C is incorrect because type 2B is a specific qualitative disorder.
d
It recommended diagnosing type 1 VWD in this group
D is is correct because the guideline recommended type 1 VWD for patients with abnormal bleeding and VWF levels below 50 IU/dL, moving many patients previously called low VWF into type 1 VWD.

Why was the 2021 guideline shift controversial?

a
It was based on the idea that VWF has no role in bleeding
A is incorrect because VWF is central to the diagnosis.
b
It balanced access to care against concern for overdiagnosis and medicalization
B is correct because the guideline prioritized access, diagnostic clarity, and avoiding delay, while critics worried that common mild bleeding plus common borderline VWF levels could lead to overdiagnosis.
c
It eliminated the need for bleeding history
C is incorrect because abnormal bleeding is part of the recommendation for the 30 to 50 IU/dL range.
d
It made type 3 VWD more common
D is incorrect because type 3 VWD remains rare and is not affected by this threshold shift.

A 55-year-old with lifelong mucocutaneous bleeding now has VWF antigen of 62 IU/dL. Earlier records show VWF antigen of 28 IU/dL at age 16. What is the best interpretation?

a
the earlier diagnosis must have been wrong
A is incorrect because earlier low values and bleeding may still have been clinically meaningful.
b
VWF levels can rise with age, so current normalization does not necessarily erase the historical phenotype
B is correct because VWF levels may increase with age. A current value is a snapshot, not a complete diagnostic history.
c
VWD cannot exist if the current VWF level is above 50 IU/dL
C is incorrect because current normalization does not automatically negate prior clinically relevant VWF deficiency.
d
this pattern proves type 2B VWD
D is incorrect because type 2B requires a specific qualitative pattern.

A clinician sees VWF antigen 46 IU/dL and VWF activity 44 IU/dL in a patient with minimal bleeding history. What is the best response?

a
Automatically diagnose type 1 VWD
A is incorrect because the diagnosis should not rest on a single borderline result without phenotype and context.
b
Automatically dismiss the result as normal variation
B is incorrect because borderline values may matter, especially in a patient with a convincing bleeding history.
c
Interpret the result in relation to bleeding phenotype, repeat testing, and context
The correct answer is C because borderline VWF values require clinical context. The significance depends on bleeding history, family history, physiologic state, sample quality, and reproducibility.
d
Diagnose type 2 VWD
D is incorrect because the antigen and activity are proportionately reduced, not discordant.

A patient has low FVIII activity with relatively preserved VWF antigen. Which diagnostic possibility should be considered?

a
Type 2N VWD or hemophilia A
The correct answer is A because type 2N VWD impairs VWF binding to FVIII and can mimic mild hemophilia A. Additional testing, such as VWF-FVIII binding or genetic testing, may be needed.
b
Type 3 VWD only
B is incorrect because type 3 VWD usually has absent or near-absent VWF.
c
Iron deficiency anemia
C is incorrect because iron deficiency does not explain disproportionate FVIII reduction.
d
Low VWF without further testing
D is incorrect because the pattern requires further evaluation.

Sort each item according to the main reasoning category it illustrates.

type 2N VWD
VWF 42 IU/dL with abnormal bleeding
type 2B VWD
VWF rising with age
repeat testing while well
blood group O
type 3 VWD
pregnancy
30 versus 50 IU/dL cutoff
Classification category
Threshold problem
Contextual modifier

Match each VWD category or concept with its best interpretation.

Low VWF
Type 1 VWD
Type 2M VWD
partial quantitative VWF deficiency
mild-to-moderate reduction in VWF that may behave as risk factor, disease-associated phenotype, or incidental finding depending on context
impaired platelet-dependent VWF function not explained by loss of high-molecular-weight multimers
Correct! Sorry, Incorrect.

Closing Note

VWD classification is not a table to memorize. It is a way of reasoning across imperfect boundaries. A threshold can support a decision, but it cannot carry the diagnosis alone.

Prev
 1 / 20 
Next